AHR and obesity due to melanocortin 4 receptor deficiency: In further support to a regulatory role of AHR in energy metabolism, serum AHR ligand activities were found to correlate with obesity and the metabolic syndrome in humans [13], and a long-term treatment with a subtoxic dose of TCDD exacerbated body weight gain on HFD in mice [14], [15].